EUNETWORKS
31.12.2020 11:08:17 CET | Business Wire | Press release
euNetworks Fiber UK Limited (“euNetworks”), a Western European bandwidth infrastructure company, today announced that it has acquired 100% of the shares of The Loop Manchester Limited (“The Loop”), from Gamma Telecom Holdings Limited (“Gamma”). The Loop is a duct and sub-duct based fibre network in Greater Manchester in the United Kingdom.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201231005050/en/
The Loop launched in 2012 and has a unique duct network stretching more than 87km across the key commercial areas of Manchester, Salford and Trafford. With over 180km of high capacity fibre cables, it connects into 20 data centres, two Exchanges and provides high capacity internet into more than 70 key multi-tenant commercial buildings. Approximately 48km of the duct network is entirely unique routing from alternative operators in the city. That routing combined with 700 chambers and expansion capability, offers a strong compliment to euNetworks current fibre network in Manchester. As well as serving the growing Manchester media sector, The Loop’s customers include major data centre operators, enterprises and public sector organisations.
euNetworks is focused on delivering high bandwidth fibre connectivity between and within cities in Europe. The company owns and operates deep fibre networks in 17 cities, including Manchester, and also operates a highly differentiated long haul network that spans 15 countries. euNetworks continues to invest in its network, building unique routes, adding multiple diverse paths and extending reach into key hyperscale data centre sites, data centre clusters and network aggregation points. These investments continue to fuel the company’s growth and are driven by the capacity requirements of euNetworks’ customers. At the heart of this is the company’s direct, diverse connectivity to over 440 data centres across Western Europe.
“Manchester is an important and growing digital hub and we have been keen to develop our presence in the city for some time. It also enhances our Super Highway that runs from Dublin through to Manchester, London and Lowestoft,” said Brady Rafuse, Chief Executive Officer of euNetworks. “The acquisition of The Loop network strengthens our customer proposition in the bandwidth infrastructure market. As well as adding unique routes to our Manchester metro, the Loop provides us with a more local presence, the flexibility to connect more data centres and buildings and the opportunity for further expansion. Prior to this acquisition, our Manchester metro consisted of 42km of duct network, 276 chambers and direct connection into 17 data centres. The combined footprint will deliver immediate value to both existing customers and our new customers that we welcome from The Loop.”
Andrew Taylor, Gamma’s Chief Executive Officer, commented: “We have developed The Loop into a successful and growing business which is now ready for its next phase and we’re really pleased that euNetworks has chosen to be its ensuing owner. euNetworks’ extensive fibre footprint across Europe and the UK coupled with their customer centred approach to network development and investment is both impressive and innovative.”
“This is a great match for The Loop and we are delighted to have been acquired by euNetworks and to be joining the team,” said Ashley Griffiths, Managing Director of The Loop. “We’ve worked closely with euNetworks for a number of years in Manchester and I know our customers will immediately benefit from this acquisition. We remain focused on delivering a great service experience as well as more fibre-based service options to our customers.”
“We anticipate a rapid integration of The Loop into euNetworks,” added Rafuse. “We are delighted to welcome Ashley and the team into the euNetworks group along with their customers and suppliers. Their local knowledge, expertise, impressive development and strong relationships in the market are invaluable as we look to grow euNetworks’ presence in the region. In addition, our focus on the media sector is immediately strengthened with their knowledge and strong reputation among the media and broadcast community in Manchester and the UK. There’s a great opportunity from the teams and the networks coming together to develop and future-proof some of the larger content requirements of these companies.”
About euNetworks
euNetworks is a bandwidth infrastructure company, owning and operating 17 fibre based metropolitan networks connected with a high capacity intercity backbone covering 51 cities in 15 countries across Europe. The company leads the market in data centre connectivity, directly connecting over 440 today. euNetworks is also a leading cloud connectivity provider and offers a targeted portfolio of metropolitan and long haul services including Dark Fibre, Wavelengths, and Ethernet. Wholesale, finance, content, media, mobile, data centre and enterprise customers benefit from euNetworks’ unique inventory of fibre and duct based assets that are tailored to fulfil their high bandwidth needs. For further information visit eunetworks.com .
About Gamma
Gamma is a leading supplier of Unified Communications as a Service (UCaaS) in the UK, German, Spanish and Dutch business markets. It is AIM listed and employs 1450 people. With a range of UCaaS, Mobile and Connectivity services, Gamma provides robust and secure solutions that enable organisations to communicate, collaborate and offer a better customer experience. Gamma focuses its family of businesses on digital automation, delivering UCaaS services to SME customers largely via a network of channel partners. For further information visit www.gammacommunicationsplc.com
About The Loop Manchester Ltd
The Loop Manchester is more than 180km of fibre network, supplying direct connectivity to data centres and ultrafast internet access to the private and public sector. The network stretches across Salford, Trafford and the city of Manchester. For further information visit https://www.theloopmanchester.co.uk/
View source version on businesswire.com: https://www.businesswire.com/news/home/20201231005050/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom